Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization
- PMID:9166930
- PMCID: PMC2223493
- DOI: 10.1038/bjc.1997.242
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization
Abstract
Comparative genomic hybridization (CGH) was used to detect copy number changes of DNA sequences in the Ewing family of tumours (ET). We analysed 20 samples from 17 patients. Fifteen tumours (75%) showed copy number changes. Gains of DNA sequences were much more frequent than losses, the majority of the gains affecting whole chromosomes or whole chromosome arms. Recurrent findings included copy number increases for chromosomes 8 (seven out of 20 samples; 35%), 1q (five samples; 25%) and 12 (five samples; 25%). The minimal common regions of these gains were the whole chromosomes 8 and 12, and 1q21-22. High-level amplifications affected 8q13-24, 1q and 1q21-22, each once. Southern blot analysis of the specimen with high-level amplification at 1q21-22 showed an amplification of FLG and SPRR3, both mapped to this region. All cases with a gain of chromosome 12 simultaneously showed a gain of chromosome 8. Comparison of CGH findings with cytogenetic analysis of the same tumours and previous cytogenetic reports of ET showed, in general, concordant results. In conclusion, our findings confirm that secondary changes, which may have prognostic significance in ET, are trisomy 8, trisomy 12 and a gain of DNA sequences in 1q.
Similar articles
- Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors.Tarkkanen M, Kiuru-Kuhlefelt S, Blomqvist C, Armengol G, Böhling T, Ekfors T, Virolainen M, Lindholm P, Monge O, Picci P, Knuutila S, Elomaa I.Tarkkanen M, et al.Cancer Genet Cytogenet. 1999 Oct 1;114(1):35-41. doi: 10.1016/s0165-4608(99)00031-x.Cancer Genet Cytogenet. 1999.PMID:10526533
- DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.Van Dekken H, Krijtenburg PJ, Alers JC.Van Dekken H, et al.Acta Histochem. 2000 Feb;102(1):85-94. doi: 10.1078/0065-1281-00540.Acta Histochem. 2000.PMID:10726167
- DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study.Kiuru-Kuhlefelt S, El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M.Kiuru-Kuhlefelt S, et al.Mod Pathol. 1998 Mar;11(3):227-31.Mod Pathol. 1998.PMID:9521467
- CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases.Brisset S, Schleiermacher G, Peter M, Mairal A, Oberlin O, Delattre O, Aurias A.Brisset S, et al.Cancer Genet Cytogenet. 2001 Oct 1;130(1):57-61. doi: 10.1016/s0165-4608(01)00454-x.Cancer Genet Cytogenet. 2001.PMID:11672775Review.
- Cytogenetic characterization of Ewing tumors using fine needle aspiration samples. a 10-year experience and review of the literature.Udayakumar AM, Sundareshan TS, Goud TM, Devi MG, Biswas S, Appaji L, Arunakumari BS, Rajan KR, Prabhakaran PS.Udayakumar AM, et al.Cancer Genet Cytogenet. 2001 May;127(1):42-8. doi: 10.1016/s0165-4608(00)00417-9.Cancer Genet Cytogenet. 2001.PMID:11408064Review.
Cited by
- An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.Shulman DS, Whittle SB, Surdez D, Bailey KM, de Álava E, Yustein JT, Shlien A, Hayashi M, Bishop AJR, Crompton BD, DuBois SG, Shukla N, Leavey PJ, Lessnick SL, Kovar H, Delattre O, Grünewald TGP, Antonescu CR, Roberts RD, Toretsky JA, Tirode F, Gorlick R, Janeway KA, Reed D, Lawlor ER, Grohar PJ.Shulman DS, et al.NPJ Precis Oncol. 2022 Sep 17;6(1):65. doi: 10.1038/s41698-022-00307-2.NPJ Precis Oncol. 2022.PMID:36115869Free PMC article.Review.
- Replication Timing Aberration ofKIF14 andMDM4 /PI3KC 2β Alleles and Aneuploidy as Markers of Chromosomal Instability and Poor Treatment Response in Ewing Family Tumor Patients.Ayala FRR, Martin JW, Bertuzzo CS.Ayala FRR, et al.Glob Med Genet. 2023 Apr 21;10(2):54-62. doi: 10.1055/s-0043-1768238. eCollection 2023 Jun.Glob Med Genet. 2023.PMID:37091312Free PMC article.
- Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.Brownhill SC, Taylor C, Burchill SA.Brownhill SC, et al.Br J Cancer. 2007 Jun 18;96(12):1914-23. doi: 10.1038/sj.bjc.6603819. Epub 2007 May 29.Br J Cancer. 2007.PMID:17533400Free PMC article.
- DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.Knuutila S, Björkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y.Knuutila S, et al.Am J Pathol. 1998 May;152(5):1107-23.Am J Pathol. 1998.PMID:9588877Free PMC article.Review.
- CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling.Ventura S, Aryee DN, Felicetti F, De Feo A, Mancarella C, Manara MC, Picci P, Colombo MP, Kovar H, Carè A, Scotlandi K.Ventura S, et al.Oncogene. 2016 Jul 28;35(30):3944-54. doi: 10.1038/onc.2015.463. Epub 2015 Nov 30.Oncogene. 2016.PMID:26616853Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous